cgmp regulations Options
No. 21 CFR 211.113(a) needs ideal created treatments being recognized and adopted during manufacturing to prevent objectionable microorganisms in drug products not required to be sterile. Additionally, the next paragraph of USP Normal Chapter Antimicrobial Effectiveness Tests reads: Antimicrobial preservatives shouldn't be applied in its p